Evan Doran

801 total citations
33 papers, 438 citations indexed

About

Evan Doran is a scholar working on Economics and Econometrics, Pharmacology and General Health Professions. According to data from OpenAlex, Evan Doran has authored 33 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Economics and Econometrics, 16 papers in Pharmacology and 12 papers in General Health Professions. Recurrent topics in Evan Doran's work include Pharmaceutical Economics and Policy (17 papers), Pharmaceutical industry and healthcare (16 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). Evan Doran is often cited by papers focused on Pharmaceutical Economics and Policy (17 papers), Pharmaceutical industry and healthcare (16 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). Evan Doran collaborates with scholars based in Australia, Canada and Ireland. Evan Doran's co-authors include David Henry, Ian Kerridge, Jane Robertson, Andrew Searles, Ray Moynihan, Paul M. McNeill, Thomas Faunce, Isobel Rolfe, Barrie Stokes and Richard O. Day and has published in prestigious journals such as PLoS ONE, Social Science & Medicine and PLoS Medicine.

In The Last Decade

Evan Doran

32 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evan Doran Australia 14 224 150 129 97 35 33 438
Christine Gilroy United States 7 66 0.3× 140 0.9× 119 0.9× 54 0.6× 38 1.1× 10 427
Amy C. Brodkey United States 11 188 0.8× 150 1.0× 201 1.6× 220 2.3× 9 0.3× 14 397
Lynn Cleary United States 8 136 0.6× 153 1.0× 163 1.3× 336 3.5× 40 1.1× 15 506
Iain Crinson United Kingdom 11 81 0.4× 130 0.9× 34 0.3× 43 0.4× 21 0.6× 18 324
Meghan McMahon Canada 13 230 1.0× 246 1.6× 50 0.4× 111 1.1× 20 0.6× 30 489
Ha T Tu United States 14 260 1.2× 342 2.3× 25 0.2× 34 0.4× 41 1.2× 26 493
Marilyn Y. Peay Australia 7 135 0.6× 105 0.7× 158 1.2× 62 0.6× 32 0.9× 12 406
Kei Mukohara Japan 9 153 0.7× 287 1.9× 56 0.4× 107 1.1× 5 0.1× 19 420
James Naughton United States 3 300 1.3× 146 1.0× 396 3.1× 164 1.7× 24 0.7× 7 512
Aparna Deshpande United States 8 131 0.6× 101 0.7× 178 1.4× 24 0.2× 66 1.9× 11 510

Countries citing papers authored by Evan Doran

Since Specialization
Citations

This map shows the geographic impact of Evan Doran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Doran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Doran more than expected).

Fields of papers citing papers by Evan Doran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan Doran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Doran. The network helps show where Evan Doran may publish in the future.

Co-authorship network of co-authors of Evan Doran

This figure shows the co-authorship network connecting the top 25 collaborators of Evan Doran. A scholar is included among the top collaborators of Evan Doran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan Doran. Evan Doran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Courtney‐Pratt, Helen, et al.. (2022). Nurses' recognition and response to unsafe practice by their peers: A qualitative descriptive analysis. Nurse Education in Practice. 63. 103387–103387. 2 indexed citations
2.
3.
Doran, Evan, David Henry, Thomas Faunce, & Andrew Searles. (2015). Australian pharmaceutical policy and the idea of innovation. NOVA (University of Newcastle, Australia). 2 indexed citations
4.
Lipworth, Wendy, Evan Doran, Ian Kerridge, & Richard O. Day. (2014). Challenges to pharmaceutical policymaking: lessons from Australia’s national medicines policy. Australian Health Review. 38(2). 160–168. 1 indexed citations
5.
Doran, Evan, et al.. (2014). Managing ethical issues in patient care and the need for clinical ethics support. Australian Health Review. 39(1). 44–50. 14 indexed citations
6.
Doran, Evan & Hans Löfgren. (2013). Drug promotion in Australia: policy contestation and the tightening of regulation. Deakin Research Online (Deakin University). 11(2). 19–41. 3 indexed citations
7.
Searles, Andrew, Evan Doran, Thomas Faunce, & David Henry. (2012). The affordability of prescription medicines in Australia: are copayments and safety net thresholds too high?. Australian Health Review. 37(1). 32–40. 15 indexed citations
8.
Doran, Evan, et al.. (2012). A Prompt to the Web: The Media and Health Information Seeking Behaviour. PLoS ONE. 7(4). e34314–e34314. 36 indexed citations
9.
Robertson, Jane, Evan Doran, David Henry, & Glenn Salkeld. (2011). Prescription medicines: decision‐making preferences of patients who receive different levels of public subsidy. Health Expectations. 17(1). 15–26. 3 indexed citations
10.
Parkinson, Lynne, Xenia Dolja‐Gore, Richard Gibson, et al.. (2011). An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?. BMC Public Health. 11(1). 892–892. 1 indexed citations
11.
Kerridge, Ian, et al.. (2010). Attitudes of physicians and public to pharmaceutical industry ‘gifts’. Internal Medicine Journal. 40(5). 335–341. 17 indexed citations
12.
Doran, Evan & Jane Robertson. (2009). Australia's pharmaceutical cost sharing policy: reducing waste or affordability?. Australian Health Review. 33(2). 231–240. 8 indexed citations
13.
Doran, Evan & David Henry. (2008). Australian Pharmaceutical Policy: Price Control, Equity, and Drug Innovation in Australia. Journal of Public Health Policy. 29(1). 106–120. 11 indexed citations
14.
Moynihan, Ray, Evan Doran, & David Henry. (2008). Disease Mongering Is Now Part of the Global Health Debate. PLoS Medicine. 5(5). e106–e106. 39 indexed citations
15.
Doran, Evan & David Henry. (2008). Disease mongering: expanding the boundaries of treatable disease. Internal Medicine Journal. 38(11). 858–861. 25 indexed citations
16.
Doran, Evan & David Henry. (2007). Global Pharmaceuticals: Ethics, Markets, Practices. Australian and New Zealand Journal of Public Health. 31(1). 91–92. 19 indexed citations
17.
Henry, David, Evan Doran, Ian Kerridge, et al.. (2005). Ties That Bind. Archives of Internal Medicine. 165(21). 2493–2493. 12 indexed citations
18.
Doran, Evan, Ian Kerridge, Paul M. McNeill, & David Henry. (2005). Empirical uncertainty and moral contest: A qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia. Social Science & Medicine. 62(6). 1510–1519. 29 indexed citations
19.
Doran, Evan, Jane Robertson, Isobel Rolfe, & David Henry. (2004). Patient co‐payments and use of prescription medicines. Australian and New Zealand Journal of Public Health. 28(1). 62–67. 23 indexed citations
20.
Doran, Evan, Jane Robertson, & David Henry. (2004). Moral hazard and prescription medicine use in Australia—the patient perspective. Social Science & Medicine. 60(7). 1437–1443. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Gilroy Breakdown of academic impact, for papers by Amy C. Brodkey Breakdown of academic impact, for papers by Lynn Cleary Breakdown of academic impact, for papers by Iain Crinson Breakdown of academic impact, for papers by Meghan McMahon Breakdown of academic impact, for papers by Ha T Tu Breakdown of academic impact, for papers by Marilyn Y. Peay Breakdown of academic impact, for papers by Kei Mukohara Breakdown of academic impact, for papers by James Naughton Breakdown of academic impact, for papers by Aparna Deshpande
Rankless by CCL
2026